EP Limited - Researches novel diagnostic and therapeutic devices. Also offer a range of consulting services in the fields of biomedical signal processing, design and implementation of digital and analog systems. Enslein Research, Inc. - Develops computational metabolism and toxicity prediction models using advanced QSAR methodologies with metabolism and toxicity databases. Tribiosys, Inc. - Bioinformatics and related research and development informatics solutions to improve decision-making in drug discovery and development by the biopharmaceutical industry. 3rd Millennium, Inc. - Bioinformatics consulting for pharmaceutical, biotech, and academic clients to design and develop research and development software solutions-from Cambridge, MA. CEBTech Services - Consulting services in fermentation technology, cell culture, bioprocess control, laboratory design, pilot plant design, bioreactor modification, biosensor development, and down stream processing. Integrative BioInformatics - Leveraging technology to bridge cell biology and genomics by providing computational biology and database technology software and consulting services for modeling complex biological problems faced by scientists in public and private research institutes, biotechnology companies, and universities. Campbell Alliance - A management consulting company providing services to pharmaceutical and healthcare companies. IMS Health - Offers information solutions for pharmaceutical and healthcare industries. Dyad Systems, LLC - A Cambridge-based, life sciences consulting company providing professional services focused on clinical trial data management and research and development data integration solutions. AnaBus - Strategic analytical consulting and knowledge management company focused on the pharmaceutical industry. Geometrick Enterprises - Services in project management, product implementation, work-flow analysis, LIMS selection, design and documentation. Includes clients, articles, presentations, and profile of consultancy operating from Okemos, MI.